| Pitfalls with Vitamin D Research in Musculoskeletal Disorders and Recommendations on How to Avoid Them | Gary KIEBZAK,Kevin NEAL,Pooya HOSSEINZADEH,Robert OLNEY,Michael A. LEVINE | 220–226 |
| Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty | Pattara WIROMRAT,Ouyporn PANAMONTA | 227–233 |
| Early Menarche is a Risk Factor for Short Stature in Young Korean Females: An Epidemiologic Study | Sol KANG,Yoon Mo KIM,Jun Ah LEE,Dong Ho KIM,Jung Sub LIM | 234–239 |
| Cases Referred from the Turkish National Screening Program: Frequency of Congenital Hypothyroidism and Etiological Distribution | Zeynep DONBALOĞLU,Şenay ERDEVE,Semra ÇETİNKAYA,Zehra AYCAN | 240–246 |
| Risk Factors for Childhood Overweight and Obesity in Ukraine and Germany | Vira YAKOVENKO,Laura HENN,Markus BETTENDORF,Natalia ZELINSKA,Galyna SOLOVIOVA,Georg F. HOFFMANN,Juergen GRULICH HENN | 247–252 |
| Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-forgestational-age, Growth Hormone-Deficient and Prader-Willi Children | Meriem GADDAS,Laurence PERİN,Yves BOUC | 253–261 |
| Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children | Deniz KIZILAY,Semra ŞEN,Betül ERSOY | 262–269 |
| No Associations Between Serum Lipid Levels or HOMA-IR and Asthma in Children and Adolescents: A NHANES Analysis | Min LU,Beirong WU,Rong QIAO,Haoxiang GU,Ying DIN,Xiaoyan DONG | 270–277 |
| The Development and Validation of a Turkish Insulin Treatment Self-management Scale Child Form (Ages 8-18) and Parent Form | ÇAĞRI ÇÖVENER ÖZÇELİK,EDA AKTAŞ,NESRİN ŞEN CELASİN,Gülten KARAHAN OKUROĞLU,ŞÜKRİYE ŞAHİN | 278–286 |
| Antimüllerian Hormone Levels of Infants with Premature Thelarche | Nursel MURATOĞLU ŞAHİN,Elvan BAYRAMOĞLU,Hatice Nursun ÖZCAN,Erdal KURNAZ,Melikşah KESKİN,ŞENAY SAVAŞ ERDEVE,SEMRA ÇETİNKAYA,ZEHRA AYCAN | 287–292 |
| Intrauterine Twin Discordancy and Partial Postnatal Catch-up Growth in a Girl with a Pathogenic IGF1R Mutation | Paula OCARANZA,Monique LOSEKOOT,Marie J. E. WALENKAMP,Christiaan DE BRUIN,Jan M. WIT,Veronica MERICQ | 293–300 |
| A Case of Cleidocranial Dysplasia with a Novel Mutation and Growth Velocity Gain with Growth Hormone Treatment | EMİNE ÇAMTOSUN,AYŞEHAN AKINCI,Emine DEMİRAL,İBRAHİM TEKEDERELİ,AHMET SIĞIRCI | 301–305 |
| A Case of the Perinatal Form Hypophosphatasia Caused by a Novel Large Duplication of the ALPL Gene and Report of One Year Followup with Enzyme Replacement Therapy | Bülent HACIHAMDİOĞLU,Gamze ÖZGÜRHAN,Catarina PEREIRA,Emre TEPELİ,Gülşen ACAR,Serdar CÖMERT | 306–310 |
| Magnesium and Anti-phosphate Treatment with Bisphosphonates for Generalised Arterial Calcification of Infancy: A Case Report | Fatma DURSUN,Tülay ATASOY ÖZTÜRK,Serçin GÜVEN,Heves KIRMIZIBEKMEZ,Gülcan Seymen KARABULUT,Sevinç KALIN,BETÜL SÖZERİ | 311–318 |
| A Patient with Berardinelli-Seip Syndrome, Novel AGPAT2 Splicesite Mutation and Concomitant Development of Non-diabetic Polyneuropathy | Joanna OSWIECIMSKA,Mateusz DAWIDZIUK,Tomasz GAMBIN,Katarzyna ZIORA,Marta MAREK,Sylwia RZONCA,D. GUİLBRİDE,Shalini JHANGIANI,Anna OBUCHOWICZ,Alicja SIKORA,James LUPSKI,Wojciech WISZNIEWSKI,Pawel GAWLINSKI | 319–326 |
| Vitamin D Deficiency and Insufficiency According to Current Criteria for Children: Vitamin D Status of Elementary School Children in Turkey | AHMET ANIK,Özgür AKBABA | 327–328 |